# Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

> **NCT00501826** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 160 (estimated)

## Conditions studied

- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Cytarabine
- **DRUG:** Dexamethasone
- **DRUG:** Doxorubicin Hydrochloride
- **DRUG:** Mercaptopurine
- **DRUG:** Methotrexate
- **DRUG:** Nelarabine
- **DRUG:** Pegaspargase
- **DRUG:** Prednisone
- **DRUG:** Venetoclax
- **DRUG:** Vincristine Sulfate

## Key facts

- **NCT ID:** NCT00501826
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2007-07-11
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501826, "Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00501826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*